Latvijas Juras Medicinas Centrs AS (LJM1R.RI)

LJM1R.RI

About

Latvijas Juras medicinas centrs AS (Latvian Maritime Medicine Center JSC or LJMC JSC) is a Latvia-based joint stock company, which is engaged in the provision of healthcare services. LJMC operates Central Hospital, Vecmilgravis Hospital and Northern Diagnostic Center, as well as Vecmilgravis Primary Health Care Center (Vecmilgra... (more)

Buy/Sell

No analyst recommendations are available for LJM1R.RI.

» Analyst Consensus

Overall

Beta:	--
Market Cap (Mil.):	Ls 1.60
Shares Outstanding (Mil.):	0.80
Dividend:	--
Yield (%):	--

Financials

	LJM1R.RI	Industry	Sector
P/E (TTM):	--	27.85	35.83
EPS (TTM):	-0.08	--	--
ROI:	-1.99	6.71	18.72
ROE:	-2.34	8.56	19.54

Latest News about LJM1R.RI

» More LJM1R.RI News

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title	Price
Latvijas Juras Medicinas Centrs AS: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Latvijas Juras medicinas centrs AS (LJM1R) - Financial Analysis Review Provider: GlobalData	$125.00 Buy
Latvijas Juras medicinas centrs AS (LJM1R) - Financial Analysis Review Provider: GlobalData	$125.00 Buy
Latvijas Juras medicinas centrs AS (LJM1R) - Financial Analysis Review Provider: GlobalData	$125.00 Buy
Latvijas Juras Medicinas Centrs JSC Provider: Datamonitor	$50.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.